(Q46174250)

English

Variations in tryptophan hydroxylase 2 linked to decreased serotonergic activity are associated with elevated risk for metabolic syndrome in depression

scientific article published on 6 January 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19125159

Variations in tryptophan hydroxylase 2 linked to decreased serotonergic activity are associated with elevated risk for metabolic syndrome in depression (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19125159

metabolic syndrome

1 reference

based on heuristic

inferred from title

object named as

S Kloiber

1

0 references

object named as

A Menke

7

0 references

Florian Holsboer

13

object named as

F Holsboer

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19125159

4

object named as

S Ripke

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19125159

Elisabeth Binder

12

object named as

E B Binder

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19125159

author name string

M A Kohli

2

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19125159

T Brueckl

3

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19125159

M Ising

5

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19125159

M Uhr

6

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19125159

P G Unschuld

8

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19125159

S Horstmann

9

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19125159

D Salyakina

10

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19125159

B Muller-Myhsok

11

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19125159

S Lucae

14

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19125159

language of work or name

0 references

publication date

6 January 2009

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19125159

Molecular Psychiatry

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19125159

15

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19125159

7

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19125159

736-747

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19125159

https://scigraph.springernature.com/pub.10.1038/mp.2008.142

0 references

The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.142

21 January 2018

The metabolic syndrome: an emerging health epidemic in women

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.142

21 January 2018

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.142

21 January 2018

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.142

21 January 2018

Depression and comorbid medical illness: the National Institute of Mental Health perspective

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.142

21 January 2018

The metabolic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.142

21 January 2018

The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.142

21 January 2018

A twin study of depression symptoms, hypertension, and heart disease in middle-aged men.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.142

21 January 2018

Depression and the metabolic syndrome in young adults: findings from the Third National Health and Nutrition Examination Survey

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.142

21 January 2018

The relationship between psychological risk attributes and the metabolic syndrome in healthy women: antecedent or consequence?

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.142

21 January 2018

Associations between anxiety, depression, and the metabolic syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.142

21 January 2018

Insulin resistance and depression: cross sectional study

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.142

21 January 2018

Major depression predicts an increase in long-term body weight variability in young adults

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.142

21 January 2018

Depression and the metabolic syndrome: gender-dependent associations

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.142

21 January 2018

The association of cardiovascular risk factor clustering related to insulin resistance syndrome (Syndrome X) between young parents and their offspring: the Bogalusa Heart Study

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.142

21 January 2018

Genetic and nutrient determinants of the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.142

21 January 2018

Genetic determinants of the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.142

21 January 2018

A hospital-based twin register of the heritability of DSM-IV unipolar depression

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.142

21 January 2018

Genetic epidemiology of major depression: review and meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.142

21 January 2018

Genetics and genomics of depression

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.142

21 January 2018

The genetics of depression: a review

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.142

21 January 2018

The metabolic syndrome is associated with reduced central serotonergic responsivity in healthy community volunteers

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.142

21 January 2018

Obesity and depression: same disease, different names?

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.142

21 January 2018

Low central nervous system serotonergic responsivity is associated with the metabolic syndrome and physical inactivity

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.142

21 January 2018

Aggressivity, suicide attempts, and depression: relationship to cerebrospinal fluid monoamine metabolite levels

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.142

21 January 2018

A systematic review of newer pharmacotherapies for depression in adults: evidence report summary

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.142

21 January 2018

Therapeutic options for modifying cardiometabolic risk factors

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.142

21 January 2018

Drug treatments for obesity: orlistat, sibutramine, and rimonabant.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.142

21 January 2018

Effect of selective serotonin reuptake inhibitors on cardiovascular morbidity and mortality

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.142

21 January 2018

Tryptophan hydroxylase-2 controls brain serotonin synthesis

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.142

21 January 2018

Analysis of tryptophan hydroxylase I and II mRNA expression in the human brain: a post-mortem study

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.142

21 January 2018

Robust and tissue-specific expression of TPH2 versus TPH1 in rat raphe and pineal gland

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.142

21 January 2018

Association of functional polymorphisms of the human tryptophan hydroxylase 2 gene with risk for bipolar disorder in Han Chinese

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.142

21 January 2018

Nested association between genetic variation in tryptophan hydroxylase II, bipolar affective disorder, and suicide attempts.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.142

21 January 2018

Association of brain-specific tryptophan hydroxylase, TPH2, with unipolar and bipolar disorder in a Northern Swedish, isolated population.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.142

21 January 2018

Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.142

21 January 2018

Haplotype-based linkage of tryptophan hydroxylase 2 to suicide attempt, major depression, and cerebrospinal fluid 5-hydroxyindoleacetic acid in 4 populations

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.142

21 January 2018

Single nucleotide polymorphism and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene in suicide victims

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.142

21 January 2018

Brain-specific tryptophan hydroxylase 2 (TPH2): a functional Pro206Ser substitution and variation in the 5'-region are associated with bipolar affective disorder

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.142

21 January 2018

Polymorphisms in the neuronal isoform of tryptophan hydroxylase 2 are associated with bipolar disorder in French Canadian pedigrees.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.142

21 January 2018

Overweight and obesity affect treatment response in major depression.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.142

21 January 2018

P2RX7, a gene coding for a purinergic ligand-gated ion channel, is associated with major depressive disorder.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.142

21 January 2018

The metabolic syndrome--a new worldwide definition

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.142

21 January 2018

NCBI Reference Sequence (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.142

21 January 2018

Chip-based genotyping by mass spectrometry

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.142

21 January 2018

Haploview: analysis and visualization of LD and haplotype maps

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.142

21 January 2018

The structure of haplotype blocks in the human genome

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.142

21 January 2018

Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.142

21 January 2018

A note on exact tests of Hardy-Weinberg equilibrium

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.142

21 January 2018

Genotypic relative risks under ordered restriction.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.142

21 January 2018

Tryptophan hydroxylase-2 gene polymorphisms in rhesus monkeys: association with hypothalamic-pituitary-adrenal axis function and in vitro gene expression.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.142

21 January 2018

The spectrum of behaviors influenced by serotonin

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.142

21 January 2018

Serotonin and suicidal behavior

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.142

21 January 2018

Serotonin and norepinephrine reuptake inhibition and eating behavior

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.142

21 January 2018

Corticotropin-releasing hormone receptor type 1-deficiency enhances hippocampal serotonergic neurotransmission: an in vivo microdialysis study in mutant mice

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.142

21 January 2018

Glucocorticoid modulation of tryptophan hydroxylase-2 protein in raphe nuclei and 5-hydroxytryptophan concentrations in frontal cortex of C57/Bl6 mice

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.142

21 January 2018

Daily rhythm of tryptophan hydroxylase-2 messenger ribonucleic acid within raphe neurons is induced by corticoid daily surge and modulated by enhanced locomotor activity

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.142

21 January 2018

Co-occurrence of metabolic syndrome with depression and anxiety in young adults: the Northern Finland 1966 Birth Cohort Study.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.142

21 January 2018

Epidemiology, implications and mechanisms underlying drug-induced weight gain in psychiatric patients.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.142

21 January 2018

How can we realize the promise of personalized antidepressant medicines?

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.142

21 January 2018

Linkage disequilibrium in finite populations

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.142

7 January 2021

based on heuristic

inferred from DOI database lookup

Tryptophan hydroxylase 2 (TPH2) haplotypes predict levels of TPH2 mRNA expression in human pons

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.142

7 January 2021

based on heuristic

inferred from DOI database lookup

The prevalence of the metabolic syndrome and type 2 diabetes mellitus in children and adolescents

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.142

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/MP.2008.142

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19125159

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19125159

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46174250&oldid=2097436442"